Legacy Advisors’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,413
Closed -$78.8K 436
2024
Q4
$78.8K Hold
20,413
0.01% 405
2024
Q3
$150K Buy
+20,413
New +$134K 0.02% 368
2024
Q2
Sell
-12,444
Closed -$122K 330
2024
Q1
$122K Buy
+12,444
New +$102K 0.02% 307

Other funds holding BAK

Legacy Advisors's BAK Position: Q1 2025 in Review

Legacy Advisors sold out of Braskem (BAK) in Q1 2025, closing a stake of 20,413 shares — an estimated $78.8K sold.

Legacy Advisors first reported a position in BAK in Q1 2024 and held it in 3 quarters. The position peaked at $150K in Q3 2024. 58 funds tracked by Wall St. Rank hold BAK as of Q1 2025.

  • Legacy Advisors reported no remaining Braskem position as of Q1 2025 after selling out during the quarter.
  • Legacy Advisors sold 20,413 Braskem shares in Q1 2025, an estimated $78.8K.
  • Legacy Advisors first reported a position in Braskem in Q1 2024 and held it in 3 quarters.
  • Legacy Advisors's Braskem position peaked at $150K in Q3 2024.
  • 58 funds tracked by Wall St. Rank held Braskem as of Q1 2025.

Based on Legacy Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.